• 17 Apr, 2026

Medicaldrafts

Transparency in Medical Education: Why Annual Assessment Reports of Medical Colleges Are in the Spotlight Introduction to the Issue

Transparency in Medical Education: Why Annual Assessment Reports of Medical Colleges Are in the Spotlight Introduction to the Issue

Explore the debate on transparency in India’s medical education. With surging MBBS and PG seats, questions arise over NMC’s annual assessment reports. Minister Anupriya Patel addresses concerns in Lok Sabha, highlighting disclosures and legal hurdles. Discover why full reports matter for students and healthcare quality, and tips for informed choices.

Police Intervention Halts Tamil Nadu Doctors’ Indefinite Fast Over Pay and Promotion Demands

Police Intervention Halts Tamil Nadu Doctors’ Indefinite Fast Over Pay and Promotion Demands

The halted indefinite hunger strike by Tamil Nadu government doctors on March 5, 2026, over pay, promotions, and working conditions. Police intervention ended the protest at Rajiv Gandhi Government General Hospital, highlighting ongoing grievances in public healthcare. Learn about FOGDA’s demands, the event’s unfolding, and broader implications for the system.

Shocking Verdict: 61-Year-Old Farmer Jailed for 22 Years After Forging Documents for Children’s MBBS Admissions

Shocking Verdict: 61-Year-Old Farmer Jailed for 22 Years After Forging Documents for Children’s MBBS Admissions

In a shocking verdict from Puducherry, 61-year-old farmer R Sivapoosanam receives a 5-year prison sentence for forging documents to secure MBBS seats for his children under the local quota. After a grueling 22-year trial, this case exposes the fierce competition in India’s medical admissions, judicial inefficiencies, and ethical pitfalls in education. It calls for reforms like better verification

Cipla’s US Subsidiary Recalls Over 400 Cartons of Anti-Cancer Drug: What It Means for Patients and the Pharma Industry

Cipla’s US Subsidiary Recalls Over 400 Cartons of Anti-Cancer Drug: What It Means for Patients and the Pharma Industry

Cipla USA has recalled over 400 cartons of Nilotinib, a generic anti-cancer drug for CML, due to minor manufacturing specs issues. This Class III recall poses no health risks but highlights quality controls in pharma. Explore implications for patients, Cipla’s stock, and the Indian generics industry in this detailed breakdown. Stay informed on USFDA updates for global drug safety.

Gland Pharma’s ₹6.29 Crore GST Dispute: What Investors Need to Know Introduction

Gland Pharma’s ₹6.29 Crore GST Dispute: What Investors Need to Know Introduction

Explore Gland Pharma’s ₹6.29 crore GST dispute from Telangana authorities over export reclassifications and credit notes for FY 2019-20. The company deems it unjustified and plans an appeal, assuring no major impact. Dive into company overview, market reactions, stock performance, and broader pharma sector implications as of March 9, 2026. Solid fundamentals persist amid short-term volatility.

'Burned with Candles, Eyebrows Shaved’: Senior MBBS Student Booked in Shocking Ragging Horror at UP Medical College

'Burned with Candles, Eyebrows Shaved’: Senior MBBS Student Booked in Shocking Ragging Horror at UP Medical College

A shocking ragging incident at Madhav Prasad Tripathi Medical College in Uttar Pradesh has sparked outrage after allegations that a senior MBBS student burned juniors with candles and a lighter, shaved eyebrows, and publicly mocked private messages. The case highlights the continuing menace of ragging in Indian medical colleges and the urgent need for strict enforcement of anti ragging laws.

Himachal Pharma Shock: SC Upholds HC Order, Allows Prosecution Over Non-Maintenance of Manufacturing Records

Himachal Pharma Shock: SC Upholds HC Order, Allows Prosecution Over Non-Maintenance of Manufacturing Records

The Supreme Court has upheld the Himachal Pradesh High Court order allowing prosecution against pharma firm SBS Biotech for failing to maintain mandatory manufacturing records. The ruling reinforces strict compliance under the Drugs and Cosmetics Act and highlights that documentation failures and GMP violations can attract serious criminal liability in India’s pharmaceutical sector.

Major Setback for RUHS: High Court Scraps ₹1000 RTI Fee for Answer Books

Major Setback for RUHS: High Court Scraps ₹1000 RTI Fee for Answer Books

The Rajasthan High Court has declared the ₹1000 RTI fee charged by RUHS for certified copies of answer books illegal. The court ruled that such charges violate RTI regulations and ordered the immediate termination of the fee structure. The judgment is expected to bring relief to medical students seeking transparency in evaluation.